Anti-DOCK8 antibody [EPR12511]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(6 Publications)
Rabbit Recombinant Monoclonal DOCK8 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 6 publications.
View Alternative Names
Dedicator of cytokinesis protein 8, DOCK8
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-DOCK8 antibody [EPR12511] (AB175208)
Intracellular flow cytometric analysis of permeabilized THP1 cells labeling DOCK8with ab175208at 1/10 dilution (red) compared to a Rabbit IgG (green).
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-DOCK8 antibody [EPR12511] (AB175208)
Immunofluorescent staining of Raji cells labeling DOCK8 with ab175208 at 1/100 dilution (green). DAPI nuclear staining (blue).
- WB
Supplier Data
Western blot - Anti-DOCK8 antibody [EPR12511] (AB175208)
All lanes:
Western blot - Anti-DOCK8 antibody [EPR12511] (ab175208) at 1/10000 dilution
Lane 1:
Raji cell lysate at 10 µg
Lane 2:
THP1 cell lysate at 10 µg
Predicted band size: 239 kDa
false
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-DOCK8 antibody [EPR12511] (AB175208)
Immunocytochemistry/Immunofluorescence analysis of Raji (human Burkitt's lymphoma) cells labelling DOCK8 with purified ab175208 at 1/500. Cells were fixed with 100% methanol. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG (ab150077) at 1/1000 dilution was used as the secondary antibody. Nuclei couterstained with DAPI (blue).
Secondary Only Control : PBS was used instead of the primary antibody as the negative control.
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
DOCK8 actively participates in immune system regulation by impacting the cytoskeletal rearrangements necessary for proper signaling and movement of immune cells. DOCK8 engages with proteins like DOCK2 and DOCK3 forming a complex that modulates these cellular mechanisms. Its function enhances the proper survival and immune response activities of leukocytes assisting in immune surveillance and pathogen clearance.
Pathways
Several immune-related signaling pathways involve DOCK8 especially the Rac-dependent pathways that affect actin polymerization. DOCK8 interacts closely with the CRK-like protein (CRKL) to mediate these processes. These pathways highlight the interaction between DOCK8 and other proteins critical to immune cell function positioning DOCK8 as an important regulator in immune system pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in pediatrics 12:1420118 PubMed39108694
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical immunology 44:170 PubMed39098944
2024
Applications
Unspecified application
Species
Unspecified reactive species
Clinical immunology (Orlando, Fla.) 195:36-44 PubMed30048691
2018
Applications
Unspecified application
Species
Unspecified reactive species
Journal of immunology (Baltimore, Md. : 1950) 198:1887-1899 PubMed28130497
2017
Applications
Unspecified application
Species
Unspecified reactive species
Immunologic research 64:260-71 PubMed26659092
2015
Applications
Unspecified application
Species
Unspecified reactive species
Developmental dynamics : an official publication o 242:1160-71 PubMed23813564
2013
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com